Characteristics of Advanced Epithelial Ovarian Cancer Patients in Dr. M. Jamil Padang Hospital


  • Reyhan Julio Azwan Obstetrics and Gynecology Department, Medical Faculty of Andalas University, Padang, West Sumatera, Indonesia
  • Syammel Muhammad Subdivision of Gynecology Oncology, Obstetrics and Gynecology Department, Medical Faculty of Andalas University, Padang, West Sumatera, Indonesia
  • Hudila Rifa Karmia Obstetrics and Gynecology Department, Medical Faculty of Andalas University, Padang, West Sumatera, Indonesia



Ovarian cancer, advanced epithelial ovarian cancer, demographic characteristics, clinical factors, optimal cytoreduction


Background: Ovarian cancer is a major global health concern, often diagnosed at advanced stages, impacting five-year survival rates. This study examines the demographic and clinical characteristics of 64 patients with advanced epithelial ovarian cancer, shedding light on the disease complexity.

Methods: Conducted at General Hospital Dr. M. Djamil Padang, this cross-sectional study analyzed patient data using SPSS. The research, approved by the Health Research Ethics Committee of Andalas University, included detailed demographic and clinical assessments.

Results: Predominantly, patients were aged 40-64, exhibited normal BMI, and a significant portion had not given birth. Evaluation of clinical factors, including Peritoneal Cancer Index (PCI) and residual tumor size, provided insights into the cohort's characteristics. Optimal cytoreduction (<1 cm residual tumor) was prevalent, emphasizing the role of surgery in enhancing survival.

Conclusion: The study underscores the multifaceted nature of advanced epithelial ovarian cancer and advocates personalized treatment approaches tailored to individual patient profiles. The findings contribute valuable insights to the existing knowledge, emphasizing the importance of age, BMI, and surgical interventions in influencing outcomes.


​Matulonis, U. A. et al. Ovarian cancer. Nat Rev Dis Primers 2, 16061, doi:10.1038/nrdp.2016.61 (2016).

​Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2016. CA Cancer J Clin 66, 7-30, doi:10.3322/caac.21332 (2016).

​Atallah, G. A., Abd Aziz, N. H., Teik, C. K., Shafiee, M. N. & Kampan, N. C. New Predictive Biomarkers for Ovarian Cancer. Diagnostics (Basel) 11, doi:10.3390/diagnostics11030465 (2021).

​Ri, K. Riset kesehatan dasar. Jakarta: Badan Penelitian dan pengembangan Kesehatan Kementrian Kesehatan RI (2013).

​Zijlstra, M. et al. Treatment Patterns and Associated Factors in Patients With Advanced Epithelial Ovarian Cancer: A Population-Based Study. International Journal of Gynecological Cancer, doi:10.1136/ijgc-2019-000489 (2019).

​Hussain, R. & Khaliq, S. Factors Linked With Prognosis in Epithelial Ovarian Cancer: A Study From Lahore, Pakistan. doi:10.53350/pjmhs2023171804 (2023).

​He, C. et al. &Lt;p>Prognostic Significance of Log(CA125)/Pci for the Resectability of Epithelial Ovarian Cancer: A Retrospective Study</P&gt. Cancer Management and Research, doi:10.2147/cmar.s223519 (2020).

​Asp, M. et al. The Role of Computed Tomography in the Assessment of Tumour Extent and the Risk of Residual Disease After Upfront Surgery in Advanced Ovarian Cancer (AOC). Archives of Gynecology and Obstetrics, doi:10.1007/s00404-022-06466-8 (2022).

​Chornokur, G., Amankwah, E. K., Schildkraut, J. M. & Phelan, C. M. Global ovarian cancer health disparities. Gynecol Oncol 129, 258-264, doi:10.1016/j.ygyno.2012.12.016 (2013).

​Mohammadian, M. et al. Variations in the incidence and mortality of ovarian cancer and their relationship with the human development index in European Countries in 2012. Biomedical Research and Therapy 4, 1541-1557 (2017).

​Chan, J. K. et al. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer 95, 1314-1320, doi:10.1038/sj.bjc.6603457 (2006).

​Zheng, G. et al. Familial risks of ovarian cancer by age at diagnosis, proband type and histology. PLoS One 13, e0205000, doi:10.1371/journal.pone.0205000 (2018).

​Chan, J. K. et al. Stages III and IV invasive epithelial ovarian carcinoma in younger versus older women: what prognostic factors are important? Obstet Gynecol 102, 156-161, doi:10.1016/s0029-7844(03)00399-5 (2003).

​Chan, J. K. et al. Differences in prognostic molecular markers between women over and under 45 years of age with advanced ovarian cancer. Clin Cancer Res 10, 8538-8543, doi:10.1158/1078-0432.Ccr-04-0626 (2004).

​Massi, D. et al. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor. Cancer 77, 1131-1136 (1996).

​Poole, E. M. et al. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness. Cancer Epidemiol Biomarkers Prev 22, 429-437, doi:10.1158/1055-9965.Epi-12-1183-t (2013).

​Ørskov, M., Iachina, M., Guldberg, R., Mogensen, O. & Mertz Nørgård, B. Predictors of mortality within 1 year after primary ovarian cancer surgery: a nationwide cohort study. BMJ Open 6, e010123, doi:10.1136/bmjopen-2015-010123 (2016).

​Olsen, C. M. et al. Obesity and the risk of epithelial ovarian cancer: a systematic review and meta-analysis. Eur J Cancer 43, 690-709, doi:10.1016/j.ejca.2006.11.010 (2007).

​Momenimovahed, Z., Tiznobaik, A., Taheri, S. & Salehiniya, H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health 11, 287-299, doi:10.2147/ijwh.S197604 (2019).

​Risch, H. A., Marrett, L. D., Jain, M. & Howe, G. R. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 144, 363-372, doi:10.1093/oxfordjournals.aje.a008937 (1996).

​Fujita, M. et al. Smoking, earlier menarche and low parity as independent risk factors for gynecologic cancers in Japanese: a case-control study. Tohoku J Exp Med 216, 297-307, doi:10.1620/tjem.216.297 (2008).

​Jordan, S. J., Webb, P. M. & Green, A. l. C. Height, Age at Menarche, and Risk of Epithelial Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention 14, 2045-2048, doi:10.1158/1055-9965.Epi-05-0085 (2005).

​Titus-Ernstoff, L. et al. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 84, 714-721, doi:10.1054/bjoc.2000.1596 (2001).

​Franceschi, S. et al. Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer 49, 57-60, doi:10.1002/ijc.2910490111 (1991).

​Lampe, B., Kroll, N., Piso, P., Forner, D. M. & Mallmann, P. Prognostic significance of Sugarbaker's peritoneal cancer index for the operability of ovarian carcinoma. Int J Gynecol Cancer 25, 135-144, doi:10.1097/igc.0000000000000327 (2015).

​Muallem, M. Z. et al. Pre-operative serum CA125, peritoneal cancer index and intra-operative mapping score as predictors of surgical results in primary epithelial ovarian cancer. Int J Gynecol Cancer 30, 62-66, doi:10.1136/ijgc-2019-000778 (2020).

​Holschneider, C. H. & Berek, J. S. Ovarian cancer: Epidemiology, biology, and prognostic factors. Seminars in Surgical Oncology 19, 3-10, doi:<3::AID-SSU2>3.0.CO;2-S (2000).

​Mousavi, A. S. et al. Can primary optimal cytoreduction be predicted in advanced epithelial ovarian cancer preoperatively? World J Surg Oncol 8, 11, doi:10.1186/1477-7819-8-11 (2010).

​Bristow, R. E., Tomacruz, R. S., Armstrong, D. K., Trimble, E. L. & Montz, F. J. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20, 1248-1259, doi:10.1200/jco.2002.20.5.1248 (2002).

​Bachmann, R. et al. Prognostic relevance of high pretreatment CA125 levels in primary serous ovarian cancer. Mol Clin Oncol 14, 8, doi:10.3892/mco.2020.2170 (2021).